Tech Company Financing Transactions
Biohaven Pharmaceuticals Funding Round
Venrock, Aisling Capital and Aperture Venture Partners participated in a $80 million capital raise for Biohaven Pharmaceuticals. The round was announced on 11/2/2016.
Transaction Overview
Company Name
Announced On
11/2/2016
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from this financing will be used to advance the company's late stage clinical programs in orphan neurologic indications and other trials in areas of large unmet medical needs. Biohaven plans to initiate Phase 2/3 studies in 4Q2016 and in 2017.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 Church St.
New Haven, CT 06510
USA
New Haven, CT 06510
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Biohaven Pharmaceuticals (NYSE: BHVN) is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vlad Coric
Chief Financial Officer
James Engelhart
Chief Medical Officer
Robert Berman
Chief Scientific Officer
Charlie Conway
Controller
David Loomis
VP - Bus. Development
Robert Croop
VP - Bus. Development
Donnie McGrath
VP - Bus. Development
Elyse Stock
VP - Operations
Lia Donahue
VP - Operations
Kim Gentile
VP - Operations
Meghan Lovegren
VP - Operations
Beth Morris
VP - Regulatory Affairs
Marianne Frost
Browse more venture capital transactions:
Prev: 11/2/2016: Mom.life venture capital transaction
Next: 11/2/2016: Endgame venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs